Medications for Hyperkalemic Periodic Paralysis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hyperkalemic Periodic Paralysis.
Found 1 Approved Drug for Hyperkalemic Periodic Paralysis
Dichlorphenamide
Brand Names
Ormalvi, Keveyis
Dichlorphenamide
Brand Names
Ormalvi, Keveyis
Form: Tablet
Method of administration: Oral
FDA approval date: August 07, 2015
Classification: Carbonic Anhydrase Inhibitor
ORMALVI is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. ORMALVI is an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances